Holen Sie sich die Stockscreener-App
18.94
1.61%
0.30
Handel nachbörslich:
19.66
0.72
+3.80%
Schlusskurs vom Vortag:
$18.64
Offen:
$19.01
24-Stunden-Volumen:
274.57K
Relative Volume:
0.71
Marktkapitalisierung:
$881.91M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
37.88
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
-3.42%
1M Leistung:
-0.16%
6M Leistung:
+94.46%
1J Leistung:
+8.66%
1-Tages-Spanne:
$18.44
$19.13
1-Wochen-Bereich:
$16.98
$19.34
52-Wochen-Spanne:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, FTI, TS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
18.94 | 867.94M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
51.56 | 75.25B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
61.25 | 58.45B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
35.03 | 28.49B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
FTI
Technipfmc Plc
|
61.82 | 24.35B | 9.81B | 952.20M | 1.54B | 2.2308 |
|
TS
Tenaris S A Adr
|
48.65 | 23.89B | 11.84B | 2.03B | 1.68B | 3.7282 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Core Laboratories Q4 Earnings Call Highlights - Defense World
Core Laboratories outlines Q1 2026 guidance of $124M–$130M revenue amid strong international demand and cost challenges - MSN
Core Laboratories N.V. (NYSE:CLB) Q4 2025 Earnings Call Transcript - Insider Monkey
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y - TradingView
Core Laboratories to Announce Q4 Earnings on February 4 - Intellectia AI
Core Laboratories Stock Under Pressure: Is This Energy Services Veteran a Contrarian Buy or a Value - AD HOC NEWS
Core Laboratories (NYSE:CLB) Shares Down 12%Here's Why - MarketBeat
Core Lab (CLB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Core Laboratories Q4 2025 earnings miss forecasts By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) Declares Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories Stock Finds Its Footing: Modest Rebound Amid Cautious Energy Sentiment - AD HOC NEWS
Core Laboratories (CLB) Anticipates Q1 Revenue Between $124M and $130M - GuruFocus
Core Laboratories (CLB) Exceeds Revenue Expectations in Q4, Boos - GuruFocus
Core Laboratories (NYSE:CLB) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Core Laboratories: Fourth Quarter Earnings Overview - Bitget
Core Laboratories: Q4 Earnings Snapshot - KTEN
Core Laboratories (NYSE:CLB) Releases Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories posts Q4 2025 results and dividend - TipRanks
(CLB) Core Laboratories Inc. Expects Q1 Revenue Range $124.0M$130.0M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Reports Q4 Revenue $138.3M, vs. FactSet Est of $132.1M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Posts Q4 Adjusted EPS $0.21 per Share, vs. FactSet Est of $0.19 - marketscreener.com
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - PR Newswire
Investors in Core Laboratories (NYSE:CLB) have unfortunately lost 47% over the last five years - Yahoo Finance
What's in Store for Core Laboratories Stock in Q4 Earnings? - Yahoo Finance
Is Core Laboratories Inc.'s (NYSE:CLB) Latest Stock Performance A Reflection Of Its Financial Health? - 富途牛牛
Core Laboratories (CLB) Expected to Announce Earnings on Wednesday - MarketBeat
EPS Watch: Can Core Laboratories Inc be the next market leaderMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Arkadios Wealth Advisors Has $609,000 Stake in Core Laboratories Inc. $CLB - Defense World
Core Laboratories (NYSE:CLB) Hits New 1-Year HighShould You Buy? - MarketBeat
Aug Analyst Calls: Does Core Laboratories Inc have declining or rising EPSWeekly Trend Summary & Smart Investment Allocation Insights - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Can Core Laboratories Inc disrupt its industry2025 Investor Takeaways & Accurate Trade Setup Notifications - baoquankhu1.vn
Can Core Laboratories Inc. stock sustain market leadership2025 Stock Rankings & Accurate Buy Signal Alerts - Bollywood Helpline
Will Core Laboratories Inc. stock attract more institutional investors2025 Pullback Review & Weekly Return Optimization Alerts - Bollywood Helpline
Merger Talk: Is Society Pass Incorporateds growth already priced inJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Aug EndMonth: What Wall Street predicts for Core Laboratories Inc stock priceGap Down & Smart Investment Allocation Insights - Bộ Nội Vụ
Core Laboratories (NYSE:CLB) vs. Baker Hughes (NASDAQ:BKR) Financial Contrast - Defense World
Why Core Laboratories Inc. stock signals breakout potentialMarket Sentiment Review & Capital Protection Trade Alerts - Улправда
Trade Report: Can Core Laboratories Inc. stock sustain market leadershipJuly 2025 PostEarnings & Entry Point Strategy Guides - Улправда
Will Core Laboratories Inc. stock deliver shareholder valueJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - Улправда
Insider Buy: Is Core Laboratories Inc. stock resilient to inflationMarket Volume Summary & Consistent Profit Trade Alerts - Улправда
What catalysts could drive Core Laboratories Inc. stock higher2025 Biggest Moves & Daily Growth Stock Investment Tips - Улправда
What insider trading reveals about Core Laboratories Inc. stockEarnings Growth Summary & Daily Chart Pattern Signal Reports - ulpravda.ru
Core Laboratories Stock's Stability Makes It a Wise Hold for Now - Finviz
Core Laboratories: Providing The Technology To Replace Tier-1 Oil Inventory (NYSE:CLB) - Seeking Alpha
Is Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st
Core Laboratories (NYSE:CLB) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL - 富途牛牛
Core Laboratories (NYSE: CLB) SVP reports vested performance share award - Stock Titan
Core Laboratories (NYSE: CLB) SVP performance share award vests at 116.5% - Stock Titan
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):